pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4251 |
Genomic Coordinates | chr1: 3127975 - 3128035 |
Description | Homo sapiens miR-4251 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4251 | |||||||||||||||
Sequence | 35| CCUGAGAAAAGGGCCAA |51 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | SOLiD | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | HTR2A | ||||||||||||||||||||
Synonyms | 5-HT2A, HTR2 | ||||||||||||||||||||
Description | 5-hydroxytryptamine receptor 2A | ||||||||||||||||||||
Transcript | NM_000621 | ||||||||||||||||||||
Other Transcripts | NM_001165947 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on HTR2A | |||||||||||||||||||||
3'UTR of HTR2A (miRNA target sites are highlighted) |
>HTR2A|NM_000621|3'UTR 1 TAGGCTAGTTGCCGTGGCAACTGTGGAAGGCACACTGAGCAAGTTTTCACCTATCTGGAAAAAAAAAAATATGAGATTGG 81 AAAAAATTAGACAAGTCTAGTGGAACCAACGATCATATCTGTATGCCTCATTTTATTCTGTCAATGAAAAGCGGGGTTCA 161 ATGCTACAAAATGTGTGCTTGGAAAATGTTCTGACAGCATTTCAGCTGTGAGCTTTCTGATACTTATTTATAACATTGTA 241 AATGATATGTCTTTAAAATGATTCACTTTTATTGTATAATTATGAAGCCCTAAGTAAATCTAAATTAACTTCTATTTTCA 321 AGTGGAAACCTTGCTGCTATGCTGTTCATTGATGACATGGGATTGAGTTGGTTACCTATTGCTGTAAATAAAAATAGCTA 401 TAAATAGTGAAAATTTTATTGAATATAATGGCCTCTTAAAAATTATCTTTAAAACTTACTATGGTATATATTTTGAAAGG 481 AGAAAAAAAAAGCCACTAAGGTCAGTGTTATAAAATCTGTATTGCTAAGATAATTAAATGAAATACTTGACAACATTTTT 561 CATTCCTGCTTTTTCATAGATACCATTTTGAAATATTCACAAGGTTGCTGGCATTTGCTGCATTTCAAGTTAATTCTCAG 641 AAGTGAAAAAGACTTCAAATGTTATTCAATAACTATTGCTGCTTTCTCTTCTACTTCTTGTGCTTTACTCTGAATTTCCA 721 GTGTGGTCTTGTTTAATATTTGTTCCTCTAGGTAAACTAGCAAAAGGATGATTTAACATTACCAAATGCCTTTCTAGCAA 801 TTGCTTCTCTAAAACAGCACTATCGAGGTATTTGGTAACTTGCTGTGAAATGACTGCATCATGCATGCACTCTTTTGAGC 881 AGTAAATGTATATTGATGTAACTGTGTCAGGATTGAGGATGAACTCAGGTTTCCGGCTACTGACAGTGGTAGAGTCCTAG 961 GACATCTCTGTAAAAAGCAGGTGACTTTCCTATGACACTCATCAGGTAAACTGATGCTTTCAGATCCATCGGTTTATACT 1041 ATTTATTAAAACCATTCTGCTTGGTTCCACAATCATCTATTGAGTGTACATTTATGTGTGAAGCAAATTTCTAGATATGA 1121 GAAATATAAAAATAATTAAAACAAAATCCTTGCCTTCAAACGAAATGGCTCGGCCAGGCACGGAGGCTCGTGCATGTAAT 1201 CCTAGCACTTTGGGAGGCTGAGATGGGAGGATCACTTGAGGCCAAGAGTTTGAGACCAACCTGGGTAACAAAGTGAGACC 1281 TCCCTGTCTCTACAAAAAAAATCAAAAAATTATCTGATCCTTGTGGCACACAACTGTGGTCCCAGCTACAGGGGAGGCTG 1361 AGACGCAAGGATCACTTGAGCCCAGAAGCTCAAGGCTGCAGTGAGCCAAGTTCACACCACTGCCATTTCCTCCTGGGCAA 1441 CAGAGTGAGACCCTATCACAAAAAAAAAGAAAGAAAAAAAGAAAATGACTAAACTGAAATGGTCTTAGTCAAAAAATATA 1521 TACAGACTTATTTTTAGAATCATTTCAACTTATTTCCTTCTTACCTGGTTCAGAAACAAGTTTGTTTCAACTGTGAGAGT 1601 AGTTTTAAAAATAAGTTTTCCTGATTGGTTACCAATAAACACCAAACAAATAAAGGAGGGGGAAAATATCACTTGAGGCT 1681 TAACATTGCAATTAATTTAGAAATACGCACCTCAATCTCAAGCCAGTTTATAACTACCATAGTTTTGAGCAAAATTTTTC 1761 TTCTATTTCTCCAAAAACTCACTCATTTCAGTATTACTCATTGACACTGGGCTCCCTAATAGAAAAGCAGATATTATAAT 1841 ATTTCATTGAAATGGTTACTAAAGAGAAAAAGAGATTAACAACAGTTAATCCACCTTGATATTATAACACTCAAGGTTAA 1921 ATTGCATGTTGTTATTAGAATCAATGTTATATATATGATTACAATGCTGAAGCATTTCTATTGAATGAGAAATAGTGTTT 2001 GCCCTAAACCTTTGGGAAAAAAATACAGATTTGAAAACTAAAGAATGTGGGAAGTGTCATTGTGTAATTTGGAAATGCAT 2081 AAAATTCTCATTATGTCCTCATAGATATGTTGAAAGATGGTTCACTGTTTCAAAGATAGAATGTATAATATGCTGCTAGT 2161 ACCAAGGCTGCATTTGAACTGAACTACTCCTTATGATATACCATACTAACTGATGAAAATATAAATGTTAAAATGTCTCC 2241 ACTCTAATGTATTTTGCCTTCACTTGTAACTCTGCACATTTCATTATATATTAGGGAAAAGATTACAGATTCTACCCCCA 2321 TATACTCAATCTTGATCAGAATGTACATTAATGTTGCCTGATAGATGTCTTTTGACTACCTATATATTACAAATGTGTAT 2401 GTGTTTTTTTCTTCCATAAGTATCTATTCAAGTGTATACTGTATAGGCAAATGTGTAGCTGTATATATGTACAGACATGT 2481 TCTCATGCACTTTATTCAATATTTATATATTTATATGGACGAAAAGCAAGTCAATGAAAACACTCAGTATATACACATGT 2561 GTGCATGTTTGTATCATGTTTATTTAAATGTGAATTCATGTTCTAATATTTCTATGACCTTCCATTGCTGCAAAGCAGAT 2641 TAAAGTGTAACAAAAATATCAGCTCTTTAAATAAACTGGAAATTAATCTAATTTTGTGGAAGAACTTTAAGACAAGTCTA 2721 TGAGGATGGCGAAAACAATGGTCCACATATATAGTTTCTTGATCCTAAATAAAATGGTACCTTTGGGCCCTTTGTTTAGT 2801 CTGGCAATTTTCTGACTACTATGGCTTTTTAAACAGACTCACACCTAAGTGAAACACAGTTGTCAAATGATTTATGGATC 2881 TGTGATTAAAGGATTCACTTTTAATGAATACTATTAAAACGGAGTAACAAACCTTGCTCTACTTTAAGTTGAATGATAGA 2961 TTCCTCTATATTCAAAAAAAAGCAATTAACTGCCATAATTAGGGAAAACTGTTTAAAGCATACTGCATTTACTTGGCCAC 3041 AGCGCCATCTCATGGTAATTTTTTAAAGTGCTACCGTAGCCAAATTGAACTAAGTCACTGTACTGCTTTCAGCAAAGGGT 3121 GCTCCTCCCATTTGTGCATCAATGAGACATATTTATAAAGTGCTAAATTATTCTGTGCCATATGTAACAAATACAGTGAA 3201 GATTATTTTATGAACTTATTTTAATCAAGGCGATGCTAAAAGTTTTCAAGAAAGGATAAATAACTGTAAATAAAGTAGAC 3281 TCAAAAATGAATGAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | BC-1 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796037. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796037 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000378688.4 | 3UTR | UCAAGUUAAUUCUCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
98 hsa-miR-4251 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT056156 | OTUD1 | OTU deubiquitinase 1 | 2 | 2 | ||||||||
MIRT080004 | MYL12B | myosin light chain 12B | 2 | 2 | ||||||||
MIRT080407 | ONECUT2 | one cut homeobox 2 | 2 | 2 | ||||||||
MIRT081901 | KCTD15 | potassium channel tetramerization domain containing 15 | 2 | 2 | ||||||||
MIRT090342 | SEC61A1 | Sec61 translocon alpha 1 subunit | 2 | 8 | ||||||||
MIRT096824 | ZSWIM6 | zinc finger SWIM-type containing 6 | 2 | 4 | ||||||||
MIRT140185 | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | 2 | 2 | ||||||||
MIRT149716 | LDLR | low density lipoprotein receptor | 2 | 6 | ||||||||
MIRT205293 | STK11IP | serine/threonine kinase 11 interacting protein | 2 | 2 | ||||||||
MIRT213265 | REST | RE1 silencing transcription factor | 2 | 6 | ||||||||
MIRT254069 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT256251 | ANKRD33B | ankyrin repeat domain 33B | 2 | 2 | ||||||||
MIRT264966 | TMEM136 | transmembrane protein 136 | 2 | 2 | ||||||||
MIRT267496 | FEN1 | flap structure-specific endonuclease 1 | 2 | 2 | ||||||||
MIRT285077 | MIER1 | MIER1 transcriptional regulator | 2 | 2 | ||||||||
MIRT296167 | NCOA3 | nuclear receptor coactivator 3 | 2 | 2 | ||||||||
MIRT316073 | ABRACL | ABRA C-terminal like | 2 | 2 | ||||||||
MIRT360286 | HIST1H3E | histone cluster 1 H3 family member e | 2 | 2 | ||||||||
MIRT364793 | PRRC2B | proline rich coiled-coil 2B | 2 | 2 | ||||||||
MIRT443277 | TSPAN15 | tetraspanin 15 | 2 | 2 | ||||||||
MIRT443453 | CLIC5 | chloride intracellular channel 5 | 2 | 2 | ||||||||
MIRT445938 | KLHL32 | kelch like family member 32 | 2 | 2 | ||||||||
MIRT448012 | HLA-DOA | major histocompatibility complex, class II, DO alpha | 2 | 2 | ||||||||
MIRT448382 | TP53INP1 | tumor protein p53 inducible nuclear protein 1 | 2 | 4 | ||||||||
MIRT448499 | RYBP | RING1 and YY1 binding protein | 2 | 2 | ||||||||
MIRT449896 | C11orf34 | placenta expressed transcript 1 | 1 | 2 | ||||||||
MIRT450457 | ZDHHC2 | zinc finger DHHC-type containing 2 | 2 | 2 | ||||||||
MIRT450849 | HTR2A | 5-hydroxytryptamine receptor 2A | 2 | 2 | ||||||||
MIRT453774 | NUCB1 | nucleobindin 1 | 2 | 10 | ||||||||
MIRT464399 | URM1 | ubiquitin related modifier 1 | 2 | 2 | ||||||||
MIRT465008 | TUBB2A | tubulin beta 2A class IIa | 2 | 8 | ||||||||
MIRT465145 | TSC22D2 | TSC22 domain family member 2 | 2 | 2 | ||||||||
MIRT467799 | SLC2A14 | solute carrier family 2 member 14 | 2 | 2 | ||||||||
MIRT472597 | NACC1 | nucleus accumbens associated 1 | 2 | 2 | ||||||||
MIRT477969 | DPM2 | dolichyl-phosphate mannosyltransferase subunit 2, regulatory | 2 | 2 | ||||||||
MIRT486586 | ZNF619 | zinc finger protein 619 | 2 | 2 | ||||||||
MIRT487739 | MICAL2 | microtubule associated monooxygenase, calponin and LIM domain containing 2 | 2 | 4 | ||||||||
MIRT492529 | PTMA | prothymosin, alpha | 2 | 6 | ||||||||
MIRT496845 | KCNIP2 | potassium voltage-gated channel interacting protein 2 | 2 | 2 | ||||||||
MIRT499064 | CTBP1 | C-terminal binding protein 1 | 2 | 4 | ||||||||
MIRT502046 | LAMTOR1 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 | 2 | 6 | ||||||||
MIRT503907 | ZSCAN25 | zinc finger and SCAN domain containing 25 | 2 | 2 | ||||||||
MIRT506776 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT510003 | UCP1 | uncoupling protein 1 | 2 | 6 | ||||||||
MIRT513040 | BRIX1 | BRX1, biogenesis of ribosomes | 2 | 2 | ||||||||
MIRT513174 | MOAP1 | modulator of apoptosis 1 | 2 | 6 | ||||||||
MIRT517592 | ZNF579 | zinc finger protein 579 | 2 | 4 | ||||||||
MIRT521825 | POLR1D | RNA polymerase I subunit D | 2 | 2 | ||||||||
MIRT530663 | TRIM56 | tripartite motif containing 56 | 2 | 2 | ||||||||
MIRT531718 | TARS | threonyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT535154 | PLEKHG5 | pleckstrin homology and RhoGEF domain containing G5 | 2 | 2 | ||||||||
MIRT536385 | LEFTY1 | left-right determination factor 1 | 2 | 2 | ||||||||
MIRT543847 | APIP | APAF1 interacting protein | 2 | 2 | ||||||||
MIRT546973 | PRKAB2 | protein kinase AMP-activated non-catalytic subunit beta 2 | 2 | 2 | ||||||||
MIRT548667 | CSRNP3 | cysteine and serine rich nuclear protein 3 | 2 | 2 | ||||||||
MIRT548799 | CLIP4 | CAP-Gly domain containing linker protein family member 4 | 2 | 4 | ||||||||
MIRT549610 | TMEM101 | transmembrane protein 101 | 2 | 2 | ||||||||
MIRT549716 | NUP37 | nucleoporin 37 | 2 | 4 | ||||||||
MIRT549873 | ZNF260 | zinc finger protein 260 | 2 | 2 | ||||||||
MIRT555383 | PPP1CC | protein phosphatase 1 catalytic subunit gamma | 2 | 2 | ||||||||
MIRT566976 | LBR | lamin B receptor | 2 | 2 | ||||||||
MIRT568052 | CHSY1 | chondroitin sulfate synthase 1 | 2 | 2 | ||||||||
MIRT570970 | TMBIM4 | transmembrane BAX inhibitor motif containing 4 | 2 | 2 | ||||||||
MIRT571174 | ZNF85 | zinc finger protein 85 | 2 | 2 | ||||||||
MIRT571364 | ZNF45 | zinc finger protein 45 | 2 | 2 | ||||||||
MIRT572309 | LSM4 | LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated | 2 | 2 | ||||||||
MIRT572493 | BTN2A2 | butyrophilin subfamily 2 member A2 | 2 | 2 | ||||||||
MIRT606783 | KIAA0040 | KIAA0040 | 2 | 5 | ||||||||
MIRT607952 | NFAM1 | NFAT activating protein with ITAM motif 1 | 2 | 10 | ||||||||
MIRT609978 | HERPUD2 | HERPUD family member 2 | 2 | 2 | ||||||||
MIRT610069 | CD300E | CD300e molecule | 2 | 2 | ||||||||
MIRT610118 | IL17REL | interleukin 17 receptor E like | 2 | 2 | ||||||||
MIRT610151 | PRMT8 | protein arginine methyltransferase 8 | 2 | 4 | ||||||||
MIRT611075 | ZNF621 | zinc finger protein 621 | 2 | 2 | ||||||||
MIRT612011 | COX17 | COX17, cytochrome c oxidase copper chaperone | 2 | 2 | ||||||||
MIRT617901 | PTCHD3 | patched domain containing 3 | 2 | 2 | ||||||||
MIRT618052 | MRVI1 | murine retrovirus integration site 1 homolog | 2 | 2 | ||||||||
MIRT619526 | ZNF74 | zinc finger protein 74 | 2 | 2 | ||||||||
MIRT624276 | CRISPLD2 | cysteine rich secretory protein LCCL domain containing 2 | 2 | 2 | ||||||||
MIRT625357 | MGLL | monoglyceride lipase | 2 | 2 | ||||||||
MIRT626756 | NDUFA9 | NADH:ubiquinone oxidoreductase subunit A9 | 2 | 2 | ||||||||
MIRT628851 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT630458 | GMPS | guanine monophosphate synthase | 2 | 2 | ||||||||
MIRT634536 | MRPS17 | mitochondrial ribosomal protein S17 | 2 | 2 | ||||||||
MIRT638806 | DCTN3 | dynactin subunit 3 | 2 | 2 | ||||||||
MIRT647607 | TMTC2 | transmembrane and tetratricopeptide repeat containing 2 | 2 | 2 | ||||||||
MIRT650885 | PPP1R15A | protein phosphatase 1 regulatory subunit 15A | 2 | 2 | ||||||||
MIRT653507 | SLC43A2 | solute carrier family 43 member 2 | 2 | 2 | ||||||||
MIRT658608 | ENTPD5 | ectonucleoside triphosphate diphosphohydrolase 5 | 2 | 2 | ||||||||
MIRT666345 | SKAP2 | src kinase associated phosphoprotein 2 | 2 | 2 | ||||||||
MIRT693743 | ACACA | acetyl-CoA carboxylase alpha | 2 | 2 | ||||||||
MIRT704049 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT709789 | CYBRD1 | cytochrome b reductase 1 | 2 | 2 | ||||||||
MIRT711837 | AMOTL2 | angiomotin like 2 | 2 | 2 | ||||||||
MIRT711875 | VASP | vasodilator stimulated phosphoprotein | 2 | 2 | ||||||||
MIRT717349 | RAB40A | RAB40A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT717746 | MYLK | myosin light chain kinase | 2 | 2 | ||||||||
MIRT725398 | LRIG2 | leucine rich repeats and immunoglobulin like domains 2 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|